Obgemsa is a medicine used to treat adults with overactive bladder syndrome (OAB). It is used to treat symptoms of the condition such as urgency (sudden urge to urinate), increased urinary frequency (need to urinate frequently) and urge incontinence (involuntary leakage when a sudden strong need to urinate is felt). Obgemsa contains the active substance vibegron.
Therapeutic Indication
### Therapeutic indication Obgemsa is indicated in symptomatic treatment of adult patients with overactive bladder (OAB) syndrome.
Therapeutic Area (MeSH)
ATC Code
G04BD15
ATC Item
vibegron
Pharmacotherapeutic Group
Urologicals
Active Substance (Summary)
INN / Common Names
EMA Name
Obgemsa
Medicine Name
Obgemsa
Aliases
N/ANo risk management plan link.
